-
Je něco špatně v tomto záznamu ?
Quality by Design as a risk-based strategy in pharmaceutical analysis: Development of a liquid chromatography-tandem mass spectrometry method for the determination of nintedanib and its impurities
B. Pasquini, S. Orlandini, S. Furlanetto, R. Gotti, M. Del Bubba, F. Boscaro, B. Bertaccini, M. Douša, G. Pieraccini,
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články
- MeSH
- chromatografie kapalinová metody MeSH
- indoly analýza chemie MeSH
- metoda Monte Carlo MeSH
- pravděpodobnost MeSH
- reprodukovatelnost výsledků MeSH
- řízení kvality MeSH
- riziko MeSH
- rozpouštědla MeSH
- tandemová hmotnostní spektrometrie metody MeSH
- Publikační typ
- časopisecké články MeSH
Nintedanib (NIN) is a tyrosine kinase inhibitor recently approved for the treatment of idiopathic pulmonary fibrosis. As a new drug, no monograph is available so far in official compendia. A liquid chromatography-tandem mass spectrometry method is presented for the simultaneous determination of NIN and its seven potential impurities. The risk-based approach of Analytical Quality by Design was applied in method development. The critical method parameters (CMPs) were the type of organic solvent in the mobile phase, formic acid percentage, column flow rate, oven temperature, gradient slope of organic eluent. The critical method attributes (CMAs) were selected as analysis time and selectivity between the main compound NIN and the adjacent peaks. Design of Experiments methodology was effectively employed for establishing the relationship between the CMPs and the CMAs. In the scouting step, a Restek Ultra AQ C18 (100 × 2.1 mm, 2.7 µm) core-shell column was selected, and then the effects of different levels of the five CMPs on the CMAs were evaluated by means of a 35//16 symmetric screening matrix. A Box-Behnken Design made it possible to obtain detailed maps of predicted CMAs throughout the investigated experimental domain, pointing out the presence of interaction and quadratic effects. The probability of meeting the specifications for the CMAs was calculated by Monte-Carlo simulations, performing a risk analysis and drawing risk of failure maps, which were used to visualize and define the method operable design region (MODR) with a probability π ≥ 90%. The final working conditions (enclosing the MODR interval) were as follows: methanol as organic solvent; formic acid percentage, 0.15% v/v; flow rate, 0.40 mL min-1 (0.37-0.43 mL min-1); oven temperature, 40 °C (38-40 °C); gradient slope of organic eluent, 14.00% eluent B min-1 (12.85-15.15% eluent B min-1). The resulting analysis time was about 10 min. Validation was carried out according to International Council for Harmonisation guidelines and the optimized method was applied to the analysis of NIN soft capsules for quality control purposes.
Department of Pharmacy and Biotechnology University of Bologna Via Belmeloro 6 40126 Bologna Italy
Mass Spectrometry Center University of Florence Viale G Pieraccini 6 50139 Florence Italy
Zentiva k s Praha U Kabelovny 130 102 37 Praha 10 Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20005778
- 003
- CZ-PrNML
- 005
- 20200518132105.0
- 007
- ta
- 008
- 200511s2020 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.chroma.2019.460615 $2 doi
- 035 __
- $a (PubMed)31630831
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Pasquini, Benedetta $u Department of Chemistry "U. Schiff", University of Florence, Via U. Schiff 6, Via della Lastruccia 3-13, 50019 Sesto Fiorentino, Florence, Italy. Electronic address: benedetta.pasquini@unifi.it.
- 245 10
- $a Quality by Design as a risk-based strategy in pharmaceutical analysis: Development of a liquid chromatography-tandem mass spectrometry method for the determination of nintedanib and its impurities / $c B. Pasquini, S. Orlandini, S. Furlanetto, R. Gotti, M. Del Bubba, F. Boscaro, B. Bertaccini, M. Douša, G. Pieraccini,
- 520 9_
- $a Nintedanib (NIN) is a tyrosine kinase inhibitor recently approved for the treatment of idiopathic pulmonary fibrosis. As a new drug, no monograph is available so far in official compendia. A liquid chromatography-tandem mass spectrometry method is presented for the simultaneous determination of NIN and its seven potential impurities. The risk-based approach of Analytical Quality by Design was applied in method development. The critical method parameters (CMPs) were the type of organic solvent in the mobile phase, formic acid percentage, column flow rate, oven temperature, gradient slope of organic eluent. The critical method attributes (CMAs) were selected as analysis time and selectivity between the main compound NIN and the adjacent peaks. Design of Experiments methodology was effectively employed for establishing the relationship between the CMPs and the CMAs. In the scouting step, a Restek Ultra AQ C18 (100 × 2.1 mm, 2.7 µm) core-shell column was selected, and then the effects of different levels of the five CMPs on the CMAs were evaluated by means of a 35//16 symmetric screening matrix. A Box-Behnken Design made it possible to obtain detailed maps of predicted CMAs throughout the investigated experimental domain, pointing out the presence of interaction and quadratic effects. The probability of meeting the specifications for the CMAs was calculated by Monte-Carlo simulations, performing a risk analysis and drawing risk of failure maps, which were used to visualize and define the method operable design region (MODR) with a probability π ≥ 90%. The final working conditions (enclosing the MODR interval) were as follows: methanol as organic solvent; formic acid percentage, 0.15% v/v; flow rate, 0.40 mL min-1 (0.37-0.43 mL min-1); oven temperature, 40 °C (38-40 °C); gradient slope of organic eluent, 14.00% eluent B min-1 (12.85-15.15% eluent B min-1). The resulting analysis time was about 10 min. Validation was carried out according to International Council for Harmonisation guidelines and the optimized method was applied to the analysis of NIN soft capsules for quality control purposes.
- 650 _2
- $a chromatografie kapalinová $x metody $7 D002853
- 650 _2
- $a indoly $x analýza $x chemie $7 D007211
- 650 _2
- $a metoda Monte Carlo $7 D009010
- 650 _2
- $a pravděpodobnost $7 D011336
- 650 _2
- $a řízení kvality $7 D011786
- 650 _2
- $a reprodukovatelnost výsledků $7 D015203
- 650 _2
- $a riziko $7 D012306
- 650 _2
- $a rozpouštědla $7 D012997
- 650 _2
- $a tandemová hmotnostní spektrometrie $x metody $7 D053719
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Orlandini, Serena $u Department of Chemistry "U. Schiff", University of Florence, Via U. Schiff 6, Via della Lastruccia 3-13, 50019 Sesto Fiorentino, Florence, Italy. Electronic address: serena.orlandini@unifi.it.
- 700 1_
- $a Furlanetto, Sandra $u Department of Chemistry "U. Schiff", University of Florence, Via U. Schiff 6, Via della Lastruccia 3-13, 50019 Sesto Fiorentino, Florence, Italy. Electronic address: sandra.furlanetto@unifi.it.
- 700 1_
- $a Gotti, Roberto $u Department of Pharmacy and Biotechnology, University of Bologna, Via Belmeloro 6, 40126 Bologna, Italy. Electronic address: roberto.gotti@unibo.it.
- 700 1_
- $a Del Bubba, Massimo $u Department of Chemistry "U. Schiff", University of Florence, Via U. Schiff 6, Via della Lastruccia 3-13, 50019 Sesto Fiorentino, Florence, Italy. Electronic address: massimo.delbubba@unifi.it.
- 700 1_
- $a Boscaro, Francesca $u Mass Spectrometry Center (CISM), University of Florence, Viale G. Pieraccini 6, 50139 Florence, Italy. Electronic address: francesca.boscaro@unifi.it.
- 700 1_
- $a Bertaccini, Bruno $u Department of Statistics, Informatics and Applications "Giuseppe Parenti" (DiSIA), University of Florence, Viale Morgagni 59, 50134 Florence, Italy. Electronic address: bruno.bertaccini@unifi.it.
- 700 1_
- $a Douša, Michal $u Zentiva, k.s. Praha, U Kabelovny 130, 102 37 Praha 10, Czech Republic. Electronic address: michal.dousa@seznam.cz.
- 700 1_
- $a Pieraccini, Giuseppe $u Mass Spectrometry Center (CISM), University of Florence, Viale G. Pieraccini 6, 50139 Florence, Italy. Electronic address: giuseppe.pieraccini@unifi.it.
- 773 0_
- $w MED00004962 $t Journal of chromatography. A $x 1873-3778 $g Roč. 1611, č. - (2020), s. 460615
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31630831 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200511 $b ABA008
- 991 __
- $a 20200518132105 $b ABA008
- 999 __
- $a ok $b bmc $g 1524636 $s 1095834
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 1611 $c - $d 460615 $e 20191010 $i 1873-3778 $m Journal of chromatography. A, Including electrophoresis and other separation methods $n J Chromatogr A $x MED00004962
- LZP __
- $a Pubmed-20200511